Stewart Katz, MD
Interventional Cardiology · Tulsa, OKNPI 1659452324
Payments from drug & device makers
Across 754 payments — averaging $28.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$10K
- Johnson & Johnson$1K
- AstraZeneca$1K
- Novartis$1K
- E.r. Squibb & Sons, L.L.C.$988
- Esperion Therapeutics, Inc.$904
- plus $6K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 89 | $9,863 |
| Johnson & Johnson | 82 | $1,437 |
| AstraZeneca | 54 | $1,315 |
| Novartis | 85 | $1,267 |
| E.r. Squibb & Sons, L.L.C. | 53 | $988 |
| Esperion Therapeutics, Inc. | 46 | $904 |
| Merck | 36 | $832 |
| Bayer | 30 | $670 |
| Sanofi-aventis U.S. LLC | 25 | $530 |
| Boehringer Ingelheim | 20 | $424 |
| Pfizer | 29 | $422 |
| Amarin Pharma, Inc. | 26 | $403 |
| Kowa Pharmaceuticals America, Inc. | 41 | $392 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $364 |
| Arbor Pharmaceuticals, Inc. | 23 | $335 |
| Philips North America LLC | 46 | $317 |
| Novo Nordisk | 7 | $314 |
| Lundbeck LLC | 9 | $175 |
| Bardy Diagnostics, Inc. | 5 | $144 |
| Azurity Pharmaceuticals, Inc. | 4 | $77 |
| Abbott | 3 | $52 |
| Kestra Medical Technology Services, Inc. | 2 | $42 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $42 |
| Medtronic | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Bard Peripheral Vascular, Inc. | 1 | $38 |
| Silk Road Medical, Inc. | 1 | $37 |
| Althera Pharmaceuticals LLC | 4 | $31 |
| Medicure Pharma Inc. | 1 | $25 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Edwards Lifesciences | 1 | $17 |
How this compares
$21,666 in reported general payments places this provider in the 75th percentile of 110 interventional cardiology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Tulsa
- Kamran MuhammadTulsa$5.7M
- Wayne LeimbachTulsa$283K
- Eugene IchinoseTulsa$145K
- Stanley ZimmermanTulsa$102K
- Tucker HarrisonTulsa$97K
- Matthew ComstockTulsa$69K
- Tom HuTulsa$57K
- Poorya FazelTulsa$29K
- Andrew KurklinskyTulsa$16K
- Rajesh ChandwaneyTulsa$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.